WO2024003749 - COMPOUNDS AND METHODS FOR DEGRADING CASEIN KINASE 1 ALPHA
National phase entry:
Publication Number
WO/2024/003749
Publication Date
04.01.2024
International Application No.
PCT/IB2023/056639
International Filing Date
27.06.2023
Title **
[English]
COMPOUNDS AND METHODS FOR DEGRADING CASEIN KINASE 1 ALPHA
[French]
COMPOSÉS ET PROCÉDÉS DE DÉGRADATION DE LA CASÉINE KINASE 1 ALPHA
Applicants **
PIN THERAPEUTICS, INC.
Inventors
JO, Hyunsun
TERRETT, Nicholas Kenneth
LEVY, Daniel Emil
DENINNO, Michael Paul
KING-UNDERWOOD, John
CHUNG, Jun-Jae
MOHANTY, Sarina
PARK, Jisu
KIM, Purum
PARK, Yuna
JAIPURI, Firoz Ali
Priority Data
63/355,840
27.06.2022
US
63/447,528
22.02.2023
US
63/471,723
07.06.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 12064 | |
| EPO | Filing, Examination, Granting | 50977 | |
| Japan | Filing, Examination, Granting | 3258 | |
| South Korea | Filing, Examination, Granting | 3164 | |
| USA | Filing, Examination, Granting | 19140 |
Total:
88,603
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided are novel compounds represented by Formula (I) which degrade CK1α (casein kinase 1 alpha), and methods of degrading CK1α, or preventing or treating blood cancer by administering the compounds to a subject in need thereof.[French]
L'invention concerne de nouveaux composés représentés par la formule (I) qui dégradent la CK1α (caséine kinase 1 alpha), et des procédés de dégradation de la CK1α, ou de prévention ou de traitement du cancer du sang par administration des composés à un sujet en ayant besoin.